Vitalijos vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 192,069 | 185,150 | 257,560 | 242,140 | 190,572 | 219,889 | 236,622 | 469,172 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -2,650 | 280 | 3,013 | -3,355 | 447 | -5,164 | 9,812 | -364 |
| Equity | 3,699 | 3,979 | 6,992 | 3,637 | 4,084 | -1,080 | 9,194 | 1,542 |
| Liabilities | 12,299 | 17,411 | 17,592 | 13,085 | 8,706 | 10,613 | 8,766 | 30,633 |
| Non-current assets | 1,069 | 411 | 57 | 4 | 4 | 4 | 4 | 4 |
| Current assets | 14,929 | 20,979 | 24,527 | 16,718 | 12,786 | 9,529 | 17,956 | 32,171 |
| Total assets | 15,998 | 21,390 | 24,584 | 16,722 | 12,790 | 9,533 | 17,960 | 32,175 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 9,317 | 7,019 | 6,152 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +14.2% | -3.6% | +39.1% | -6.0% | -21.3% | +15.4% | +7.6% | +98.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -16.6% | 1.3% | 12.3% | -20.1% | 3.5% | -54.2% | 54.6% | -1.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -71.6% | 7.0% | 43.1% | -92.2% | 10.9% | - | 106.7% | -23.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -1.4% | 0.2% | 1.2% | -1.4% | 0.2% | -2.3% | 4.1% | -0.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 3.3 | 4.4 | 2.5 | 3.6 | 2.1 | - | 1.0 | 19.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 36,585 | 43,565 | 64,390 | 60,535 | 95,286 | 109,945 | 123,453 | 234,586 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vitalijos vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-07-18 | 2023-08-01 | 0.56 |
| 2023-06-16 | 2023-07-11 | 0.56 |
| 2023-05-16 | 2023-06-13 | 0.56 |
| 2023-05-02 | 2023-05-14 | 0.56 |
| 2023-04-18 | 2023-04-28 | 0.56 |
| 2023-03-16 | 2023-04-16 | 0.56 |
| 2023-02-17 | 2023-03-13 | 0.56 |
| 2023-02-06 | 2023-02-06 | 0.56 |
| 2023-01-23 | 2023-02-03 | 0.56 |
| 2022-12-16 | 2022-12-18 | 667.96 |
| 2022-05-17 | 2022-06-07 | 0.76 |
| 2022-04-19 | 2022-05-08 | 0.76 |
| 2022-03-16 | 2022-04-07 | 0.76 |
| 2022-02-17 | 2022-03-09 | 0.76 |
| 2022-01-18 | 2022-02-13 | 0.76 |
| 2021-12-16 | 2022-01-13 | 0.76 |
| 2021-11-16 | 2021-12-09 | 0.76 |
Vitalijos vaistinė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-04 | 2025-04-04 | 1.12 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vitalijos vaistine, UAB (code 304305358) is a Private Limited Liability Company engaged in retail sale of pharmaceutical products. In 2025, revenue increased to €469.2K, up 98.3% year on year and 113.4% over two years, after €219.9K in 2023 and €236.6K in 2024. Profitability was uneven across the period: the company recorded a net loss of €5.2K in 2023, a net profit of €9.8K in 2024, and a small loss of €364 in 2025. The 2025 profit margin was -0.1%, indicating that operations were close to breakeven despite the higher sales base. The balance sheet expanded materially, with total assets rising to €32.2K in 2025 from €18.0K in 2024 and €9.5K in 2023. Equity amounted to €1.5K, while liabilities reached €30.6K, showing a highly leveraged structure. For 2025, ROE was -23.6%, ROA -1.1%, debt-to-equity 19.87, and asset turnover 14.58x. Revenue per employee was €234.6K, while profit per employee was -€182.